MEDNAX (MD) Tops Q4 EPS by 4c, Beats on Revenues; 1Q18 EPS Guidance Above Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/4/2026
- Wall Street ends lower as Middle East tensions escalate
- Broadcom results, guidance beat on soaring AI chip sales; stock slips after hours
- Broadcom's sales and AI chip forecast comes in below expectations, shares tumble
- SpaceX sets IPO price at $135 ahead of roadshow in break with Wall Street norms
- Oil gains as Middle East hostilities flare
- Morgan Stanley lifts MU and SNDK targets, sees 2-3 years of tight memory supply
- Navitas showcases 800V power delivery board at NVIDIA MGX ecosystem event
- Inotiv files for bankruptcy with $65 million financing commitment
- Broadcom results, guidance beat on soaring AI chip sales; stock slips after hours
- Wall Street ends lower as Middle East tensions escalate
- After-Hours Stock Movers: AVGO, CRWD, FIVE, AI, TLYS, NTSK,
- After-Hours Stock Movers: PANW, CRWD, ZS, GTLB, ULTA
- After-Hours Stock Movers: HPE, CRDO, FULC, ABVX, MCHP
- After-Hours Stock Movers: DELL, MDB, AEO, NTAP, GAP, S, ADSK
- After-Hours Stock Movers: CRM, MRVL, SNOW, HPQ, DDOG, MDB, P, SNPS, BRZE, NCNO
Mednax (MD) PT Raised to $57 at Citi
February 12, 2018 6:22 AM ESTCiti raised its price target on Mednax (NYSE: MD) to $57.00 (from $47.00) while maintaining a Neutral rating.
... MoreMednax (MD) PT Raised to $62 at Stephens; Reiterates Overweight
February 9, 2018 8:05 AM ESTStephens raised its price target on Mednax (NYSE: MD) to $62.00 (from $55.00) while maintaining a Overweight rating following the company's 4Q earnings report. The 4Q17 adjusted EBITDA margin declined 340bps to 17% Y/Y driven entirely by a 360bps increase in Practice Salaries and Benefits to 67.8%. Organic... More
